The authors provide an overview of the contribution of metabolomics and lipidomics in clinical studies to identify biomarkers associated with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis.
[Nature Reviews Gastroenterology & Hepatology]